CHENGHUI PHARMACEUTICAL GROUP LTD !

<
>

New products

The company is committed

to drug synthesis in fields of nutrition, narcotic...

Products of the company are mainly exported to more

than 40 countries and areas...

R&D products

During the 12th Five-Year Plan, Chenghui Shuangda will

 continue to regard...

API

Intermediates

CHENGHUI PHARMACEUTICAL GROUP LTD was founded in June 2002, with a registered capital of 130 million yuan, headquartered in the famous historical and cultural city of Jinan, Shandong Province, which is surrounded by lotus flowers and willows, and a city of mountains and half a city of lakes. It is a high-tech enterprise focusing on the research and development, production, sales and service of pharmaceutical APIs, intermediates and fine chemicals, and is committed to the research and development and application of new technologies in the fields of MAH, CDMO, veterinary medicine and agrochemicals, etc. The Group now has one R&D center, which is located in Jinan, Shandong Province.

 

Jinan Chenghui Shuangda

Chemical Co., Ltd is a high-tech enterprise which...

 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide

Sugammadex sodium

CAS:
343306-79-6
Specifications:
Y20200001107 A /GMP/WC
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide

Lidocaine

CAS:
137-58-6
Specifications:
Y20200000994 A /GMP/WC
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide

Ropivacaine hydrochloride

CAS:
132112-35-7
Specifications:
Y20220000839 A /CEP
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide
 (S)-N-(2′,6′-dimethylphenl)-2-Piperidine Carboxamide

LeterMovir

CAS:
917389-32-3
Specifications:
Y20240000270 I
Our company accepts "The Method of Extraction and Resolution of Phenylalanine by Use of D-dialkyl Tartrate" transfered by Jinan University, and has acquired the exclusive transfer. Now our company has new development in the research of phenylalanine.
On September 25, 2024, our API Ropivacaine Hydrochloride obtained the Certificate of Suitability of...
China’s four kinds of medicine markets are expanding steadily
Exhibition Introduction CPHI Milan 2024 (Wo...
Our company accepts "The Method of Extraction and Resolution of Phenylalanine by Use of D-dialkyl Tartrate" transfered by Jinan University, and has acquired the exclusive transfer. Now our company has new development in the research of phenylalanine.

copyright CHENGHUI PHARMACEUTICAL GROUP LTD 鲁ICP备09070256号-1

Product Center

Registered products              Other products              Intermediates              R&D products             

News and information

Company News       Trade News      

About Us

Production

Global customers

JOIN US

Contact Us

Sales  center 

EXPORT  DEPT. :

Tel:+86-531-58897029/58897070

Email:sales@jnchsd.com   market@jnchsd.com    

XML 地图